At Bloomberg, Jason Gale and Ashleigh Furlong recently reported on the groundbreaking work of Professor Hashim Ahmed, Chair of Urology at Imperial College London. Their feature highlights how Ahmed and his team are pioneering a new way forward in prostate cancer treatment - one that could save lives while sparing men from many of the harsh side effects of conventional approaches. Summary For decades, men with prostate cancer have been faced with a stark choice: live with the disea...

We’re delighted to announce a collaboration between GFCT Treatment Support, Vista Health (part of the InHealth Group), and Aqua Medical to provide NHS hospitals with a range of cost-effective and flexible options for MRI scans, ongoing biopsies or a mixture of both as outlined in the attached summary document. What’s on Offer  Mobile MRI Scanning Unit  Available at current NHS tariffs: £149 (non-contrast) and £273 (contrast)....

Did you know that a raised PSA doesn’t always mean cancer? It could point to an enlarged prostate - a common condition with effective treatments available. One treatment option that we would like to particularly highlight is Aquablation therapy. Who is it for? Whilst it is understood, Aquablation is NOT currently a suitable treatment for prostate cancer. It is further understood that there are some ongoing clinical trials to determine if it could help in certain circumstance...

Thanks to the support of Vista Health, part of the InHealth Group, we are delighted to offer hospitals the use of a mobile MRI Scanning Unit at the current NHS tariffs of £147 for a reported non contrast scan and £212 for a reported contrast scan. This incredibly attractive offer is based on a consecutive minimum two, but preferably four-day visit by the scanning unit on hospital premises. The target will be twenty scans a day, thereby helping reduce backlogs and bottleneck...

We're delighted to announce a new collaboration with Vista Health, one of the country's leading scanning providers with over 50 sites in the UK. Why a prostate MRI?  Provides a highly detailed view of your prostate  MRI scans can reveal signs of prostate cancer, even before changes appear in PSA levels  Is a non-invasive, quick, and pain-free procedure GFCT Treatment Support are subsidising MRI scans making them a more accessible option, improving vital...

Our founder, Graham Fulford MBE, has been invited to a parliamentary reception at the House of Commons to be held on October 14th, at which Prostate Cancer Research aim to demonstrate how targeted prostate cancer screening can be introduced across the UK. This cross-party event, sponsored by APPG on Prostate Cancer Chair Calvin Bailey MBE MP, the Rt Hon David Lammy MP, and PCR Ambassador the Rt Hon Rishi Sunak MP, will bring together the prostate cancer community, campaign supporters&n...

Most of you will be aware that there's a clear disparity in many aspects of our life depending on where you live, and the same goes for the speed of diagnosis of prostate cancer, which, like most cancers, has a much better chance of cure if found early. Our Current Work We've already introduced two measures to try to narrow this gap. Any man who has a PSA test via our system and who receives a “Red” result will be given information on how, with his GP's support,...

Graham Fulford, founder of GFCT and GFCT Treatment Support, was diagnosed with prostate cancer early this year. An update from Graham: You may remember from my last update that following the Prostatype report, the next leg was a flow test and bladder scan. The good news on the first part is that "it is a very impressive flow pattern with a maximum flow of 35m/s and a perfect curve". The not quite so good news is that the bladder scan indicated that whilst I man...

At GFCT Treatment Support, we are committed to advancing the availability of all prostate cancer treatments, especially focal therapies such as High Intensity Focused Ultrasound (HIFU). These minimally invasive treatments can be life-changing for thousands of men each year, offering effective cancer control with significantly reduced side effects compared to radical surgery or radiotherapy. Through our work, we’re supporting NHS hospitals by helping equip them with the technology need...

We recently changed our name from GFCT Focal Therapy Ltd to GFCT Treatment Support Ltd to better reflect our broader commitment to supporting all prostate cancer treatment options and helping ease pressure points in the healthcare system. A recent example is our donation of an ultrasound machine to Scunthorpe General Hospital, enabling the launch of two new one-stop clinics for prostate cancer treatment across Humberside and Lincolnshire. This initiative is already ...